Literature DB >> 24762435

Mesenchymal gene program-expressing ovarian cancer spheroids exhibit enhanced mesothelial clearance.

Rachel A Davidowitz, Laura M Selfors, Marcin P Iwanicki, Kevin M Elias, Alison Karst, Huiying Piao, Tan A Ince, Michael G Drage, Judy Dering, Gottfried E Konecny, Ursula Matulonis, Gordon B Mills, Dennis J Slamon, Ronny Drapkin, Joan S Brugge.   

Abstract

Metastatic dissemination of ovarian tumors involves the invasion of tumor cell clusters into the mesothelial cell lining of peritoneal cavity organs; however, the tumor-specific factors that allow ovarian cancer cells to spread are unclear. We used an in vitro assay that models the initial step of ovarian cancer metastasis, clearance of the mesothelial cell layer, to examine the clearance ability of a large panel of both established and primary ovarian tumor cells. Comparison of the gene and protein expression profiles of clearance-competent and clearance-incompetent cells revealed that mesenchymal genes are enriched in tumor populations that display strong clearance activity, while epithelial genes are enriched in those with weak or undetectable activity. Overexpression of transcription factors SNAI1, TWIST1, and ZEB1, which regulate the epithelial-to-mesenchymal transition (EMT), promoted mesothelial clearance in cell lines with weak activity, while knockdown of the EMT-regulatory transcription factors TWIST1 and ZEB1 attenuated mesothelial clearance in ovarian cancer cell lines with strong activity. These findings provide important insights into the mechanisms associated with metastatic progression of ovarian cancer and suggest that inhibiting pathways that drive mesenchymal programs may suppress tumor cell invasion of peritoneal tissues.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 24762435      PMCID: PMC4038562          DOI: 10.1172/JCI69815

Source DB:  PubMed          Journal:  J Clin Invest        ISSN: 0021-9738            Impact factor:   14.808


  63 in total

1.  Tubal and ovarian pathways to pelvic epithelial cancer: a pathological perspective.

Authors:  Jurgen M J Piek; René H M Verheijen; Paul J van Diest
Journal:  Histopathology       Date:  2009-03       Impact factor: 5.087

Review 2.  The ins and outs of the epithelial to mesenchymal transition in health and disease.

Authors:  M Angela Nieto
Journal:  Annu Rev Cell Dev Biol       Date:  2011-07-08       Impact factor: 13.827

3.  Reverse phase protein array: validation of a novel proteomic technology and utility for analysis of primary leukemia specimens and hematopoietic stem cells.

Authors:  Raoul Tibes; Yihua Qiu; Yiling Lu; Bryan Hennessy; Michael Andreeff; Gordon B Mills; Steven M Kornblau
Journal:  Mol Cancer Ther       Date:  2006-10       Impact factor: 6.261

4.  Role of integrin receptors for fibronectin, collagen and laminin in the regulation of ovarian carcinoma functions in response to a matrix microenvironment.

Authors:  Nuzhat Ahmed; Clyde Riley; Greg Rice; Michael Quinn
Journal:  Clin Exp Metastasis       Date:  2005       Impact factor: 5.150

5.  Vitronectin and its receptors partly mediate adhesion of ovarian cancer cells to peritoneal mesothelium in vitro.

Authors:  Loraine Heyman; Sabrina Kellouche; Julien Fernandes; Soizic Dutoit; Laurent Poulain; Franck Carreiras
Journal:  Tumour Biol       Date:  2008-09-09

Review 6.  Organotypic models of metastasis: A three-dimensional culture mimicking the human peritoneum and omentum for the study of the early steps of ovarian cancer metastasis.

Authors:  Hilary A Kenny; Songuel Dogan; Marion Zillhardt; Anirban K Mitra; S Diane Yamada; Thomas Krausz; Ernst Lengyel
Journal:  Cancer Treat Res       Date:  2009

Review 7.  Reduced proliferation and enhanced migration: two sides of the same coin? Molecular mechanisms of metastatic progression by YB-1.

Authors:  Valentina Evdokimova; Cristina Tognon; Tony Ng; Poul H B Sorensen
Journal:  Cell Cycle       Date:  2009-09-16       Impact factor: 4.534

8.  Binding of ovarian cancer cells to peritoneal mesothelium in vitro is partly mediated by CD44H.

Authors:  S A Cannistra; G S Kansas; J Niloff; B DeFranzo; Y Kim; C Ottensmeier
Journal:  Cancer Res       Date:  1993-08-15       Impact factor: 12.701

Review 9.  Multicellular spheroids in ovarian cancer metastases: Biology and pathology.

Authors:  Kristy Shield; M Leigh Ackland; Nuzhat Ahmed; Gregory E Rice
Journal:  Gynecol Oncol       Date:  2009-01-10       Impact factor: 5.482

10.  Epithelial-mesenchymal transition in ovarian carcinoma.

Authors:  Ben Davidson; Claes G Tropé; Reuven Reich
Journal:  Front Oncol       Date:  2012-04-10       Impact factor: 6.244

View more
  65 in total

1.  Establishment of a New Ovarian Cancer Cell Line CA5171.

Authors:  Ying-Cheng Chiang; Wen-Fang Cheng; Ming-Cheng Chang; Tzu-Pin Lu; Kuan-Ting Kuo; Hsiu-Ping Lin; Chang-Yao Hsieh; Chi-An Chen
Journal:  Reprod Sci       Date:  2014-11-12       Impact factor: 3.060

Review 2.  Metastasis Organotropism: Redefining the Congenial Soil.

Authors:  Yang Gao; Igor Bado; Hai Wang; Weijie Zhang; Jeffrey M Rosen; Xiang H-F Zhang
Journal:  Dev Cell       Date:  2019-05-06       Impact factor: 12.270

3.  Lysophosphatidic Acid Initiates Epithelial to Mesenchymal Transition and Induces β-Catenin-mediated Transcription in Epithelial Ovarian Carcinoma.

Authors:  Rebecca J Burkhalter; Suzanne D Westfall; Yueying Liu; M Sharon Stack
Journal:  J Biol Chem       Date:  2015-07-14       Impact factor: 5.157

4.  Mutant p53 regulates ovarian cancer transformed phenotypes through autocrine matrix deposition.

Authors:  Marcin P Iwanicki; Hsing-Yu Chen; Claudia Iavarone; Ioannis K Zervantonakis; Taru Muranen; Marián Novak; Tan A Ince; Ronny Drapkin; Joan S Brugge
Journal:  JCI Insight       Date:  2016-07-07

5.  A single-cell landscape of high-grade serous ovarian cancer.

Authors:  Benjamin Izar; Itay Tirosh; Elizabeth H Stover; Isaac Wakiro; Michael S Cuoco; Idan Alter; Christopher Rodman; Rachel Leeson; Mei-Ju Su; Parin Shah; Marcin Iwanicki; Sarah R Walker; Abhay Kanodia; Johannes C Melms; Shaolin Mei; Jia-Ren Lin; Caroline B M Porter; Michal Slyper; Julia Waldman; Livnat Jerby-Arnon; Orr Ashenberg; Titus J Brinker; Caitlin Mills; Meri Rogava; Sébastien Vigneau; Peter K Sorger; Levi A Garraway; Panagiotis A Konstantinopoulos; Joyce F Liu; Ursula Matulonis; Bruce E Johnson; Orit Rozenblatt-Rosen; Asaf Rotem; Aviv Regev
Journal:  Nat Med       Date:  2020-06-22       Impact factor: 53.440

6.  Post-translational modification of the membrane type 1 matrix metalloproteinase (MT1-MMP) cytoplasmic tail impacts ovarian cancer multicellular aggregate dynamics.

Authors:  Jing Yang; William C Kasberg; Angela Celo; Zhong Liang; Kristal Quispe; M Sharon Stack
Journal:  J Biol Chem       Date:  2017-06-27       Impact factor: 5.157

Review 7.  Consensus reference gene(s) for gene expression studies in human cancers: end of the tunnel visible?

Authors:  R N Sharan; S Thangminlal Vaiphei; Saibadaiahun Nongrum; Joshua Keppen; Mandahakani Ksoo
Journal:  Cell Oncol (Dordr)       Date:  2015-09-18       Impact factor: 6.730

Review 8.  Imaging innate immune responses at tumour initiation: new insights from fish and flies.

Authors:  Yi Feng; Paul Martin
Journal:  Nat Rev Cancer       Date:  2015-08-20       Impact factor: 60.716

Review 9.  Three-dimensional modeling of ovarian cancer.

Authors:  Erin A White; Hilary A Kenny; Ernst Lengyel
Journal:  Adv Drug Deliv Rev       Date:  2014-07-14       Impact factor: 15.470

10.  Collagen-rich omentum is a premetastatic niche for integrin α2-mediated peritoneal metastasis.

Authors:  Yen-Lin Huang; Ching-Yeu Liang; Danilo Ritz; Ricardo Coelho; Dedy Septiadi; Manuela Estermann; Cécile Cumin; Natalie Rimmer; Andreas Schötzau; Mónica Núñez López; André Fedier; Martina Konantz; Tatjana Vlajnic; Diego Calabrese; Claudia Lengerke; Leonor David; Barbara Rothen-Rutishauser; Francis Jacob; Viola Heinzelmann-Schwarz
Journal:  Elife       Date:  2020-10-07       Impact factor: 8.140

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.